Thursday, May 26, 2022
High Yields Cannabis/Marijuana/ Weed News
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
High Yields
No Result
View All Result
Home Cannabis Stock Quotes & News

Ketamine One Provides Updated Information for Stock

Jeremy Vedder by Jeremy Vedder
October 21, 2021
in Cannabis Stock Quotes & News
0
Ketamine One Provides Updated Information for Stock

VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, announces that, as the result of its previously announced spin-out transaction of Milgauss Investments Ltd. (“Milgauss”), certain information related to the listing of its common shares on the OTC Markets and the Frankfurt Stock Exchange has been changed.

As of October 15, 2021, Ketamine One’s common shares have a new CUSIP number of 492556105 and a new ISIN number of CA4925561058. Ketamine One’s listing on the OTC Markets remains under the “KONEF” stock ticker symbol, while its profile has now been labeled as “KetamineOne Capital Ltd New”. On the Frankfurt Stock Exchange, the Company’s listing has had its stock ticker symbol changed from “MYO” to “6FC” and its WKN number changed from “A3CRYC” to “A3C5JN”.

READ ALSO

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

How to throw the cannabis wedding of your dreams

The Company is also working with OTC Markets and other applicable regulatory agencies to become “15c2-11 Certified” under Rule 15c2-11 of the Securities and Exchange Commission of the United States. Becoming 15c2-11 Certified could rectify the status of Ketamine One’s common shares not being eligible for proprietary broker-dealer quotations and being labeled as “Unsolicited-Only”, which can make it difficult for investors to trade in the common shares of the Company through their brokerage firms. Unsolicited-Only stocks are described by OTC Markets as having a higher risk of wider spreads, increased volatility, and price dislocations.

To recap the Milgauss transaction, the common shares of Ketamine One outstanding immediately prior to the completion of the arrangement were redesignated as Class A common shares, which were subsequently exchanged for: (i) one new common share of Ketamine One (the “New Ketamine One Share”); and (ii) one-110th of a Milgauss share (each whole share being a Milgauss share) for each Ketamine One share held before the effective date of the transaction. Ketamine One’s shares were delisted from the NEO Exchange effective as of the close of business on Thursday, Oct. 14, 2021. Then, the New Ketamine One Shares were listed for trading on the NEO Exchange effective as of market opening on Friday, Oct. 15, 2021 under the same “MEDI” trading symbol as the Ketamine One shares. As a result, Milgauss is now a privately held reporting issuer following the closing of the transaction.

ABOUT KETAMINE ONE

KetamineOne Capital Limited is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. Currently, Ketamine One has a network of clinics across North America, with plans to further consolidate the highly fragmented industry. The recent addition of KGK Science Inc. as the Company’s contract research division also places the company at the forefront of premium clinical research based on its extensive experience in pharmaceuticals, cannabis, and the emerging psychedelic medicine industries. As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy.

On behalf of:

KETAMINE ONE

“Adam Deffett“
Adam Deffett, Interim CEO

For further information, please contact:

Nick Kuzyk, Investor Relations
Tel: 1-844-PHONE-K1 (1-844-746-6351)
Email: IR@ketamine.one
Web: www.ketamine.one
Twitter: @KetamineOne

Notice Regarding Forward-Looking Information:

This news release contains forward-looking statements including but not limited to statements regarding the Company’s business, assets or investments, as well as other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and future prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

[Original Source]

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0

Related Posts

Fire & Flower and Hifyre announce proposed acquisition of PotGuide
Cannabis Stock Quotes & News

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
How to throw the cannabis wedding of your dreams
Cannabis Stock Quotes & News

How to throw the cannabis wedding of your dreams

May 26, 2022
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO
Cannabis Stock Quotes & News

California cannabis companies brace for environmental law compliance

May 26, 2022
Aleafia Health Announces the Appointment of Mark J. Sandler
Cannabis Stock Quotes & News

California DCC debuts data tool showcasing access areas for cannabis businesses

May 26, 2022
Best Cannabis Seeds For Sale Online
Cannabis Stock Quotes & News

Cannabis consumption lounges coming to Grover Beach

May 26, 2022
Eaze launches first dispensaries in San Diego and Santa Ana
Cannabis Stock Quotes & News

Rubicon Organics Amends and Grants Stock Options

May 26, 2022
Next Post
Jushi Closes Ohio Cannabis Processor Acquisition – New Cannabis Ventures

Jushi Holdings Inc. Opens its 25th Retail Location

  • Trending
  • Comments
  • Latest
Monthly Spotlight: The Best of Plain Jane CBD

Monthly Spotlight: The Best of Plain Jane CBD

April 8, 2022
The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

April 19, 2022
volcano hybrid review 2022

The 2022 Volcano Hybrid Vaporizer Review: All You Need To Know

May 23, 2022
The Utillian 5 v3 Wax Pen Review for 2022

The Utillian 5 v3 Wax Pen Review for 2022

March 27, 2022

The 7 Best Smell-Proof Weed Bags To Keep Your Bud Stash Safe

April 27, 2022
The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

May 23, 2022
The 10 Best Smell Proof Backpacks for Weed in 2022

The 10 Best Smell Proof Backpacks for Weed in 2022

May 5, 2022
Fire & Flower and Hifyre announce proposed acquisition of PotGuide

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

0
Major Marijuana Coalition Forms To Coordinate Legalization Push, But Some Key Advocacy Players Aren’t Involved

Major Marijuana Coalition Forms To Coordinate Legalization Push

0
MMJRecs - cannabis leaf

How Medical Marijuana Can Help Treat Sleep Disorders

0
Colorado Cannabis Sales Exceed $2 Billion in 2020

Colorado Cannabis Sales Exceed $2 Billion in 2020

0
Fire & Flower and Hifyre announce proposed acquisition of PotGuide

New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs

May 26, 2022
How to throw the cannabis wedding of your dreams

How to throw the cannabis wedding of your dreams

May 26, 2022
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO

California cannabis companies brace for environmental law compliance

May 26, 2022
American Green, Inc.™ (OTC:ERBB) Earns Five Year Cannabis

Harborside Q1 Revenue Increases 14% Sequentially to $17.2 Million Ahead of Becoming StateHouse

May 26, 2022

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • March 2020

Categories

  • 1933 Industries
  • 4front Ventures
  • Acreage Holdings
  • Ascend Wellness
  • Ayr Wellness
  • Body & Mind
  • C21 Investments
  • Cannabis Stock Quotes & News
  • Cansortium Inc
  • Captor Capital
  • Ceres Acquisition Corp
  • Chalice Brands
  • Columbia Care
  • Cresco Labs
  • CuraLeaf
  • Gage Growth
  • Glass House Brands
  • Green Thumb Industries
  • Grown Rogue International
  • Harborside
  • Item 9 Labs
  • Jushi Holdings
  • Lowell Farms
  • MariMed
  • MedMen Enterprises
  • News
  • Next Green Wave
  • Planet 13
  • Plus Products
  • Product Reviews
  • Red White & Bloom
  • SLANG Worldwide
  • Sol Global Investments
  • TerrAscend
  • TILT Holdings
  • Trulieve
  • Verano Holdings
  • Vext Sciences
  • Vibe Growth

Recent Posts

  • New York’s Office of Cannabis Management ask TikTok to allow educational cannabis PSAs
  • How to throw the cannabis wedding of your dreams
  • California cannabis companies brace for environmental law compliance
  • Harborside Q1 Revenue Increases 14% Sequentially to $17.2 Million Ahead of Becoming StateHouse

QR Code

Ketamine One Provides Updated Information for Stock
No Result
View All Result
  • Homepages
    • Home Page 1
  • News

© 2021 High Yields